SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-01-532125
Filing Date
2001-09-13
Accepted
2001-09-13 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a2059101zsc13da.htm SC 13D/A 104680
  Complete submission text file 0000912057-01-532125.txt   106918
Mailing Address 1375 AKRON STREET COPIAGUE NY 11726
Business Address 1375 AKRON STREET P O BOX 1001 COPIAGUE NY 11726 5167892600
AMERICAN BIOGENETIC SCIENCES INC (Subject) CIK: 0000856984 (see all company filings)

IRS No.: 112655906 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45379 | Film No.: 1736450
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice